Rein Therapeutics Inc. (RNTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Rein Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$0.71
+1.49% today
Market cap
$61M
Overall quality
—
Kronos AI 30-day
—
Rein Therapeutics Inc. (RNTX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $61M. It trades at $0.71, up 1.49% today. 2 analysts' average target of $6.00 implies +745.1% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $6.00 |
| Low – high | $4.00 – $8.00 |
| Analysts | 2 |
| Upside to average | +745.1% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.